{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Philadelphia",
      "address_1": "1100 Orthodox St",
      "reason_for_recall": "Labeling: Incorrect instructions; an error in section 5.11 of the patient insert that results in incorrect medical advice.  Specifically, the labeling should read \"If a severely depressed HDL-C level is detected, fibrate therapy should be withdrawn, and the HDL-C level monitored until it has returned to baseline, and fibrate therapy should not be re-initiated.\"  The labeling for the recalled lots",
      "address_2": "",
      "product_quantity": "",
      "code_info": "Lot 6561703, exp. 03/14",
      "center_classification_date": "20140106",
      "distribution_pattern": "Nationwide and  Puerto Rico.",
      "state": "PA",
      "product_description": "Fenofibric Acid, immediate release tablet, 35 mg, 30 count bottle Rx only, Mutual Pharmaceutical Co., Inc., Philadelphia, PA 19124 USA NDC  53489-677-07",
      "report_date": "20140115",
      "classification": "Class III",
      "openfda": {},
      "recalling_firm": "Mutual Pharmaceutical Company,  Inc.",
      "recall_number": "D-399-2014",
      "initial_firm_notification": "Letter",
      "product_type": "Drugs",
      "event_id": "64727",
      "termination_date": "20140401",
      "more_code_info": "",
      "recall_initiation_date": "20130227",
      "postal_code": "19124-3168",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}